MORE►
Dr. George Church
The Colossal Woolly Mice. [Photo: Business Wire]
Meet the Colossal Woolly Mouse, Created by Dallas-Based ‘Decacorn’ Colossal Biosciences
by David Seeley | Mar 4, 2025
Before Colossal Biosciences can "de-extinct" the woolly mammoth, some small steps are in order. They've now been taken by the Colossal Woolly Mouse—a gene-edited creation with "dramatically altered coat color, texture, and thickness reminiscent of the woolly mammoth’s core phenotypes."
by Lance Murray |
Jan 14, 2025
The funding will support groundbreaking research into artificial womb technologies with the goal of protecting endangered species and advancing wildlife conservation efforts, the foundation said.
MORE►
by Lance Murray |
Mar 19, 2024
Dallas-based Colossal said that in her new role, MacArthur Award winner Beth Shapiro will oversee continued expansion of the company's de-extinction and conservation science teams. The company previously announced plans to "de-extinct" the woolly mammoth, the Tasmanian tiger, and the dodo bird.
MORE►
by Lance Murray |
Feb 21, 2024
Colossal Biosciences and production partner Teton Ridge Entertainment have signed with James Reed, director of the Oscar-winning Netflix documentary "My Octopus Teacher," and his company Underdog Films, to produce the docuseries.
MORE►
The Tasmanian tiger went extinct due to human hunting nearly 100 years ago. Now Dallas-based Colossal Biosciences aims to bring it back with the help of "marsupial biobanking." [Image: Colossal Biosciences]
Dallas-Based Colossal Is ‘De-Extincting’ the Tasmanian Tiger
by David Seeley | Aug 16, 2022
Colossal is already working to "de-extinct" the woolly mammoth via a mammoth-elephant hybrid project. Now the Tasmanian tiger—which went extinct nearly 100 years ago due to human hunting—is the second species Colossal is seeking to bring back.
"We’re thrilled to be collaborating with Andrew Pask and the University of Melbourne to restore this amazing animal to Earth," said Ben Lamm, Colossal's co-founder and CEO.
MORE►
by Kevin Cummings |
Mar 21, 2022
What companies are finding funding or having a big exit? From startup investments to grants and acquisitions, Dallas Innovates tracks what’s happening in North Texas money.
MORE►
by Quincy Preston and David Seeley |
Mar 9, 2022
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid.
With a total raise of $75 million to date, the startup aims to
have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE►
by David Seeley |
Sep 13, 2021
It's not "Jurassic Park," but it's almost as amazing. Hypergiant founder Ben Lamm is launching a new biosciences and genetics startup—Colossal—with $15 million in private funding. The goal: Use genomics to "de-extinct" the woolly mammoth and re-wild it on the Arctic tundra. Lamm's co-founder, Harvard geneticist Dr. George Church, says this "grand vision" could lead to big opportunities in conservation, biodiversity, carbon sequestration, and more.
MORE►
